EMPA treatment decreased medullar ACE2 mRNA expression in PCOS compared to untreated PCOS (2.43 ± 0.26 vs. 3.40 ± 0.22, p < 0.05), though it did not affect cortical expression. The gene discussed is ACE2; the disease is polycystic ovary syndrome.